Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
p16 Expression as a predictive biomarker of hypoxic cell-sensitizing agents in oropharyngeal cancer.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
p16 Expression as a predictive biomarker of hypoxic cell-sensitizing agents in oropharyngeal cancer.
p16 Expression as a predictive biomarker of hypoxic cell-sensitizing agents in oropharyngeal cancer. J Clin Oncol. 2010 Sep 20; 28(27):4103-4.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Squamous Cell
Cell Hypoxia
Chemotherapy, Adjuvant
Cisplatin
Cyclin-Dependent Kinase Inhibitor p16
Disease-Free Survival
DNA, Viral
Humans
Neoplasm Recurrence, Local
Neoplasm Staging
Oropharyngeal Neoplasms
Papillomaviridae
Radiotherapy, Adjuvant
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome
Triazines